• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个性化腹膜后肉瘤的手术切缘

Personalizing surgical margins in retroperitoneal sarcomas.

作者信息

Callegaro Dario, Fiore Marco, Gronchi Alessandro

机构信息

Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian, 1 - 20133 Milan, Italy.

出版信息

Expert Rev Anticancer Ther. 2015 May;15(5):553-67. doi: 10.1586/14737140.2015.1028375. Epub 2015 Mar 23.

DOI:10.1586/14737140.2015.1028375
PMID:25797538
Abstract

Retroperitoneal sarcomas are a group of diseases that behave differently from one another. Well-differentiated liposarcomas have an indolent biology but show a tendency to recur locally even years after primary resection. Dedifferentiated liposarcomas are characterized by a very high local recurrence risk, while the metastatic risk mainly depends on the histological characteristics of the dedifferentiated component. In leiomyosarcomas, hematogenous spread informs prognosis while local recurrences are far less common. Surgery is the cornerstone of treatment of all retroperitoneal sarcoma subtypes and its quality is the only treatment-related factor able to improve the oncological outcome. A frontline extended surgical approach is all the more critical in subtypes in which local control directly impacts prognosis.

摘要

腹膜后肉瘤是一组生物学行为各异的疾病。高分化脂肪肉瘤生物学行为惰性,但即使在初次切除数年之后仍有局部复发倾向。去分化脂肪肉瘤的特点是局部复发风险极高,而转移风险主要取决于去分化成分的组织学特征。在平滑肌肉瘤中,血行转移决定预后,而局部复发则较为少见。手术是所有腹膜后肉瘤亚型治疗的基石,手术质量是唯一能够改善肿瘤治疗结局的治疗相关因素。对于局部控制直接影响预后的亚型,一线扩大手术方式尤为关键。

相似文献

1
Personalizing surgical margins in retroperitoneal sarcomas.个性化腹膜后肉瘤的手术切缘
Expert Rev Anticancer Ther. 2015 May;15(5):553-67. doi: 10.1586/14737140.2015.1028375. Epub 2015 Mar 23.
2
[Retroperitoneal sarcomas: diagnostic and therapy].[腹膜后肉瘤:诊断与治疗]
Zentralbl Chir. 2006 Jun;131(3):223-9. doi: 10.1055/s-2006-933466.
3
Personalizing surgical margins in retroperitoneal sarcomas: an update.个性化腹膜后肉瘤的手术切缘:更新。
Expert Rev Anticancer Ther. 2019 Jul;19(7):613-631. doi: 10.1080/14737140.2019.1625774. Epub 2019 Jun 8.
4
The importance of surgical margins in retroperitoneal sarcoma.手术切缘在腹膜后肉瘤中的重要性。
J Surg Oncol. 2016 Mar;113(3):270-6. doi: 10.1002/jso.24135. Epub 2015 Dec 28.
5
Needle tract seeding following core biopsies in retroperitoneal sarcoma.腹膜后肉瘤经皮穿刺活检后的针道种植。
Eur J Surg Oncol. 2017 Sep;43(9):1740-1745. doi: 10.1016/j.ejso.2017.06.009. Epub 2017 Jun 24.
6
Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.腹膜后和躯干肉瘤:预后取决于类型而非位置。
Ann Surg Oncol. 2007 Mar;14(3):1114-22. doi: 10.1245/s10434-006-9255-x. Epub 2007 Jan 7.
7
Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients.腹膜后软组织肉瘤:117例原发性和复发性疾病的预后与治疗
Anticancer Res. 2006 Mar-Apr;26(2B):1577-81.
8
Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.腹膜后脂肪肉瘤:对86例脂肪肉瘤和恶性纤维组织细胞瘤进行临床病理复查后对去分化的随访分析
Cancer. 2006 Jun 15;106(12):2725-33. doi: 10.1002/cncr.21933.
9
Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.腹膜后肉瘤初次扩大切除术后复发后的结局:跨大西洋腹膜后肉瘤工作组的报告
Cancer. 2017 Jun 1;123(11):1971-1978. doi: 10.1002/cncr.30572. Epub 2017 Feb 2.
10
Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease.腹膜后软组织肉瘤:原发性和复发性疾病的预后与治疗
Am Surg. 2000 Sep;66(9):832-6.

引用本文的文献

1
ASO Practice Guidelines Series: Multidisciplinary Management of Retroperitoneal Sarcomas.血管球囊成形术实践指南系列:腹膜后肉瘤的多学科管理
Ann Surg Oncol. 2025 May 9. doi: 10.1245/s10434-025-17284-y.
2
Preoperative Platelet/Albumin Ratio Predicts Morbidity and Mortality in Patients with Retroperitoneal Liposarcoma.术前血小板/白蛋白比值可预测腹膜后脂肪肉瘤患者的发病率和死亡率。
Indian J Surg Oncol. 2025 Apr;16(2):558-566. doi: 10.1007/s13193-024-02106-6. Epub 2024 Oct 4.
3
Comprehensive treatment strategy for improving surgical resection rate of retroperitoneal sarcomas: a histology-specific approach narrative review.
提高腹膜后肉瘤手术切除率的综合治疗策略:组织学特异性方法的叙述性综述
Front Oncol. 2024 Oct 7;14:1432900. doi: 10.3389/fonc.2024.1432900. eCollection 2024.
4
Primary pelvic soft tissue sarcomas (PELVISARC): outcomes from the TransAtlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).原发性盆腔软组织肉瘤(PELVISARC):来自跨大西洋澳大利亚腹膜后肉瘤工作组(TARPSWG)的结果。
Br J Surg. 2024 May 3;111(5). doi: 10.1093/bjs/znae128.
5
Multivisceral resection of primary multifocal retroperitoneal sarcomas: a retrospective study from a high-volume sarcoma center.原发性多灶性腹膜后肉瘤的多脏器切除术:一项来自高容量肉瘤中心的回顾性研究。
J Clin Transl Res. 2023 Mar 28;9(2):101-109. eCollection 2023 Apr 28.
6
Organ Infiltration and Patient Risk After Multivisceral Surgery for Primary Retroperitoneal Liposarcomas.原发腹膜后脂肪肉瘤的多脏器手术后器官浸润和患者风险。
Ann Surg Oncol. 2023 Jul;30(7):4500-4510. doi: 10.1245/s10434-023-13314-9. Epub 2023 Mar 17.
7
Surgical Principles of Primary Retroperitoneal Sarcoma in the Era of Personalized Treatment: A Review of the Frontline Extended Surgery.个性化治疗时代原发性腹膜后肉瘤的外科原则:一线扩大手术综述
Cancers (Basel). 2022 Aug 24;14(17):4091. doi: 10.3390/cancers14174091.
8
A systematic review of margin status in retroperitoneal liposarcomas: Does the R0 margin matter?腹膜后脂肪肉瘤切缘状态的系统评价:R0切缘重要吗?
Front Oncol. 2022 Aug 11;12:891710. doi: 10.3389/fonc.2022.891710. eCollection 2022.
9
Prophylactic Ureteral Catheter Placement Appears to Reduce Intraoperative Ureteric Injury During Resection of Primary Retroperitoneal Liposarcoma.预防性输尿管置管似乎可减少原发性腹膜后脂肪肉瘤切除术中的输尿管损伤。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221087831. doi: 10.1177/15330338221087831.
10
Retroperitoneal Sarcoma Care in 2021.2021年腹膜后肉瘤的治疗
Cancers (Basel). 2022 Mar 2;14(5):1293. doi: 10.3390/cancers14051293.